PSI Advisors’s Avanos Medical AVNS Stock Holding History

PSI Advisors’s Portfolio AVNS Stock Details AVNS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-2	Closed	-$45	–	807
2023 Q4	$45	Hold	2	–	–	﹤0.01%	869
2023 Q3	$40	Buy	+2	New	+$45	﹤0.01%	852

Other funds holding AVNS

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

RGM Capital Naples, Florida $2.06B AUM 8.49% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

WHG

Westwood Holdings Group Dallas, Texas $13.7B AUM 21.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return

Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return

PIM

Paradice Investment Management Denver, Colorado $532M AUM 29.6% 1-Year Est. Return

PSI Advisors's AVNS Position: Q1 2024 in Review

PSI Advisors sold out of Avanos Medical (AVNS) in Q1 2024, closing a stake of 2 shares — an estimated $45 sold.

PSI Advisors first reported a position in AVNS in Q3 2023 and held it in 2 quarters. The position peaked at $45 in Q4 2023. 261 funds tracked by Wall St. Rank hold AVNS as of Q1 2024.

PSI Advisors reported no remaining Avanos Medical position as of Q1 2024 after selling out during the quarter.
PSI Advisors sold 2 Avanos Medical shares in Q1 2024, an estimated $45.
PSI Advisors first reported a position in Avanos Medical in Q3 2023 and held it in 2 quarters.
PSI Advisors's Avanos Medical position peaked at $45 in Q4 2023.
261 funds tracked by Wall St. Rank held Avanos Medical as of Q1 2024.

Based on PSI Advisors's 13F filing for Q1 2024, filed 24 Apr 2024.